About Celecure News Pipeline Our Team Partnering with Celecure Careers at Celecure Contact	News 03.06.09Celecure continues as a key partner in Competence Centre for Cancer Research Competence Centre for Cancer Research receives a 6-year grant support to advance R&D cooperation. 10.06.08EUREKA Secretariat approves Celecure's project under the Eurostars programme Celecure received excellent ranking under Europe's funding program for the SME's the EUREKA's Eurostars Programme. 10.01.07Celecure receives 1.6 million euros from four founders of Skype Investment group Ambient Sound Investments (ASI) has agreed to invest 1.6 million euros in Estonian biotechnology drug developer Celecure to accelerate the international breakthrough of its projects. 21.11.06Celecure Group opened Cancer Clinic 12.11.04Celecure signs licensing deal with Angitia AB Swedish company Angitia AB and Estonian company Celecure AS sign a worldwide licensing agreement for a novel angiogenesis inhibitor for treatment of cancer.
Celecure ASAkadeemia 15, 12618 Tallinn, Estoniatel +372 6204350info@celecure.com